Home/Filings/4/0001013762-23-003530
4//SEC Filing

Bartushak Jaime 4

Accession 0001013762-23-003530

CIK 0001506251other

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 4:15 PM ET

Size

17.9 KB

Accession

0001013762-23-003530

Insider Transaction Report

Form 4
Period: 2023-10-10
Bartushak Jaime
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Purchase Common Stock)

    2023-10-10+300,000300,000 total
    Exercise: $0.70Exp: 2033-10-10Common Stock (300,000 underlying)
Holdings
  • Common Stock

    60,353
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $3.45Exp: 2027-09-15Common Stock (25,000 underlying)
    25,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.01Exp: 2030-10-06Common Stock (125,000 underlying)
    125,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.25Exp: 2032-10-04Common Stock (300,000 underlying)
    300,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $2.00Exp: 2031-07-22Common Stock (100,000 underlying)
    100,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $0.67Exp: 2029-10-08Common Stock (100,000 underlying)
    100,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $2.04Exp: 2031-10-11Common Stock (300,000 underlying)
    300,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.62Exp: 2028-09-04Common Stock (70,000 underlying)
    70,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $10.50Exp: 2026-07-06Common Stock (48,267 underlying)
    48,267
Footnotes (9)
  • [F1]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
  • [F2]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
  • [F3]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
  • [F4]The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
  • [F5]The options vested in full on October 6, 2023.
  • [F6]The options vested in full on October 8, 2022.
  • [F7]The options vested in full on September 4, 2021.
  • [F8]the options vested in full on September 12, 2020.
  • [F9]The options vested in full on July 7, 2019.

Documents

1 file

Issuer

Citius Pharmaceuticals, Inc.

CIK 0001506251

Entity typeother

Related Parties

1
  • filerCIK 0001725077

Filing Metadata

Form type
4
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 4:15 PM ET
Size
17.9 KB